<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140274" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Heterochromia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lui</surname>
            <given-names>Forshing</given-names>
          </name>
          <aff>CA Northstate Uni, College of Med</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Stokkermans</surname>
            <given-names>Thomas J.</given-names>
          </name>
          <aff>University Hospitals of Cleveland</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Forshing Lui declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thomas Stokkermans declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>25</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140274.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Heterochromia or heterochromia iridum indicates a difference between the color of the two irises. It usually involves the whole iris and can less commonly affect only part of the iris (sectoral heterochromia). It is an often under-recognized sign of both systemic and ocular congenital or acquired diseases. This activity reviews the evaluation and management of patients with heterochromia and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the anatomy and embryology of the human iris with respect to pigmentation and color.</p></list-item><list-item><p>Summarize the causes and differential diagnosis of heterochromia.</p></list-item><list-item><p>Outline the important elements in the assessment of patients with heterochromia.</p></list-item><list-item><p>Explain the treatment of patients with heterochromia.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140274&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140274">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140274.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Heterochromia or heterochromia iridum indicates a difference between the color of the two irises.&#x000a0; It&#x000a0;can involve the whole iris&#x000a0;or&#x000a0;only part of the iris (sectoral heterochromia).<xref ref-type="bibr" rid="article-140274.r1">[1]</xref></p>
        <p>It is easier to understand the determinants of iris color with the anatomy of the iris in mind. The iris and the ciliary body constitute the anterior uveal coat. The iris is composed of two anatomical layers that both contain pigment. The iris stroma is the anterior layer, consisting of loose collagenous connective tissue, the sphincter and dilator pupillae muscles, blood vessels, nerves, melanocytes, and other cells. The posterior layer (the iris pigment epithelium) consists of two layers of cuboidal epithelium. The pigment epithelium layer is derived embryologically from the anterior part of the optic cup, and hence neuroectodermal in origin. The iris stroma is mainly mesenchymal in origin. The melanocytes within the iris stroma and the ciliary body are all derived from neurocrest cells.&#x000a0;</p>
        <p>Another important concept is the amount, type, and location of the pigment present.&#x000a0; A type of cell called a melanocyte produces melanin that is deposited in melanosomes.&#x000a0; Variation in the&#x000a0;number of melanosomes and the amount of pigment in each melanosome present in the anterior iris stroma determines eye color.&#x000a0; The type of pigment affects eye color as well.&#x000a0; The main two types of pigment are eumelanin (brown to black pigment) and pheomelanin (red to yellow pigment). Eumelanin is present in the iris pigment epithelium, while both eumelanin and pheomelanin are present in the iris stroma.&#x000a0; Lipofuscin (yellow in appearance) can accumulate with age and/or ocular disease. Eumelanin is present in the iris, brain, and hair and comes in a brown and black form. Pheomelanin is present in the iris, hair, lips, nipples, glans penis, and vagina and comes in a red and yellow form. The relative presence of the different types of eumelanin and pheomelanin determines both hair and iris color.&#x000a0; Both groups of pigment form from L-tyrosine that is converted to L-dopaquinone by tyrosinase.&#x000a0; Tyrosinase-related protein-1, in turn, converts L-dopaquinone to eumelanin while the addition of cysteine forms pheomelanin.<xref ref-type="bibr" rid="article-140274.r2">[2]</xref></p>
        <p>Genetics plays an important role in determining eye color, with up to 150 genes involved and two genes, OCA2 and HERC2, on chromosome 15, playing a significant role. OCA2 produces "P protein," which promotes melanosome maturation, and HERC2, in turn, controls OCA2.&#x000a0; The inheritance of iris color is largely determined by two genes as well, EYCL1 (also called the gey gene) and EYCL3 (also called the bey2 gene). The gey gene has a green and blue allele, and the bey2 gene has a brown and blue allele. The brown allele is dominant over the green allele, and both are dominant over the blue allele.<xref ref-type="bibr" rid="article-140274.r3">[3]</xref>&#x000a0;Since many other genes play a role as well, this occasionally creates unexpected iris color. Congenital heterochromia can be inherited, and autosomal dominant inheritance has been reported.<xref ref-type="bibr" rid="article-140274.r4">[4]</xref>&#x000a0;In many cases, however, genetic mosaicism occurs when genetic recombination or a mutation occurs during mitosis, creating an organism with genetically different cells.&#x000a0; In albinism, both the iris stroma and the iris pigment epithelium are affected.&#x000a0; Oculocutaneous albinism is inherited in an autosomal recessive manner and caused by mutations in tyrosinase, tyrosinase-related protein-1, and OCA2. Ocular albinism is inherited in a sex-linked recessive manner.&#x000a0;&#x000a0;</p>
        <p>Eye color changes from lighter tints to darker during the first year of life, with most changes occurring between 3 and 6 months of age. These changes are dependent on adrenergic innervation. Horner syndrome's lack of adrenergic innervation causes a lighter-colored iris that will have a smaller pupil in dark conditions.<xref ref-type="bibr" rid="article-140274.r5">[5]</xref></p>
        <p>Other structures within the iris and elsewhere may affect the color of the iris as well. First, iris atrophy from conditions such as pigment dispersion syndrome as well as an iridocorneal endothelial syndrome, and iris damage such as caused by surgery or injury can cause heterochromia. Second, anisocoria (different pupil size), which can&#x000a0;result from ocular trauma, Adie's pupil, or Horner syndrome, or an abnormal pupil such as is the case with iris coloboma, can create the impression of heterochromia.<xref ref-type="bibr" rid="article-140274.r6">[6]</xref>&#x000a0;Neoplastic or hamartomas structures within the iris such as iris naevi and Lisch nodules can cause heterochromia as well.&#x000a0; Finally, asymmetrical corneal changes such as band keratopathy, scarring, or edema can create the impression of heterochromia.</p>
        <p>Finally, several optical phenomena and light conditions can affect the appearance of the iris.&#x000a0; For example, reduced ambient light can cause an amber eye to appear brown. Selective absorption and reflection of other (non-pigment) molecules such as hemoglobin and collagen describe most of the variations in eye color that are not attributed to pigmentation of the iris.&#x000a0; However, Rayleigh (causing the blue appearance of the sky) and Tyndall scattering, as well as diffraction, can contribute to eye color as well.&#x000a0; Raman scattering and constructive interference (responsible for the coloration of bird and butterfly feathers and brightly colored irises of many animals) do not play a role in human iris coloration.</p>
        <p>In addition to the color, human iris tissue may form complex patterns with distinct features. These distinct features can be used for automatic personal identification like fingerprints.</p>
      </sec>
      <sec id="article-140274.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most cases of heterochromia are sporadic and isolated benign conditions without any clinical significance.</p>
        <p>The most important group of conditions with heterochromia are congenital heterochromia&#x000a0;which may be the only presentation of congenital Horner syndrome. There may be associated miosis, partial ptosis, and facial anhidrosis. Not all of these signs need to be present to be diagnosed as congenital Horner syndrome. The iris stromal melanocytes derive from neurocrest cells in embryological development. The sympathetic neurons also derive from neurocrest cells. Any disruption of sympathetic innervation of the iris melanocytes due to disruption of the post-ganglionic cervical sympathetic pathways, especially early in life as in congenital Horner syndrome, will result in decreased brown melanin color of one iris and heterochromia. Any syndromic illness associated with impaired neurocrest cells or tissues development and migration may also cause heterochromia, such as Waardenburg syndrome and Parry-Romberg syndrome. Other congenital diseases include ocular melanosis and neurocutaneous syndromes such as Sturge-Weber syndrome (abnormal hyperpigmented iris),&#x000a0;oculodermal melanocytosis (nevus of Ota), and neurofibromatosis type I (von Recklinghausen disease, iris hamartoma).<xref ref-type="bibr" rid="article-140274.r1">[1]</xref></p>
        <p>
<bold>Congenital Causes of Heterochromia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Benign heterochromia</p>
          </list-item>
          <list-item>
            <p>Congenital Horner syndrome:&#x000a0;with other presentations of miosis, partial ptosis, and/or impaired facial sweating (anhydrosis)<xref ref-type="bibr" rid="article-140274.r7">[7]</xref><xref ref-type="bibr" rid="article-140274.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>Waardenburg syndrome:&#x000a0;hearing loss, heterochromia, lateral displacement of medial canthus, hypertrichosis of medial eyebrows, and prominent broad nasal root<xref ref-type="bibr" rid="article-140274.r8">[8]</xref></p>
          </list-item>
          <list-item>
            <p>Parry-Romberg syndrome:&#x000a0;progressive facial hemiatrophy<xref ref-type="bibr" rid="article-140274.r9">[9]</xref></p>
          </list-item>
          <list-item>
            <p>Sturge-Weber syndrome:&#x000a0;facial port-wine stain with meningeal angiomatosis. Patients may present with unilateral neurological deficits, seizures, and a large facial nevus. The ipsilateral eye may have melanocytosis of the uveal coat and retina. Glaucoma is not an uncommon complication.<xref ref-type="bibr" rid="article-140274.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p>Neurofibromatosis I: Lisch nodules in the iris associated with other clinical features. Children with NF1 may also develop optic nerve pathway glioma, which can be detected by simple ophthalmoscopy showing the absence of red reflex in one eye.<xref ref-type="bibr" rid="article-140274.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>Oculodermal melanocytosis:&#x000a0;hamartomatous congenital melanocytosis<xref ref-type="bibr" rid="article-140274.r12">[12]</xref></p>
          </list-item>
          <list-item>
            <p>Iridocorneal endothelial (ICE) syndromes<xref ref-type="bibr" rid="article-140274.r13">[13]</xref></p>
          </list-item>
          <list-item>
            <p>Iris ectropion syndrome</p>
          </list-item>
          <list-item>
            <p>Incontinentia pigmenti<xref ref-type="bibr" rid="article-140274.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Acquired Causes of Heterochromia</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Acquired Horner syndrome</p>
          </list-item>
          <list-item>
            <p>Other causes of sympathetic heterochromia such as neuroblastoma&#x000a0;or paravertebral neurilemmoma<xref ref-type="bibr" rid="article-140274.r15">[15]</xref><xref ref-type="bibr" rid="article-140274.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Ocular trauma</p>
          </list-item>
          <list-item>
            <p>Fuchs heterochromic iridocyclitis<xref ref-type="bibr" rid="article-140274.r17">[17]</xref> (Fuchs heterochromic&#x000a0;uveitis)</p>
          </list-item>
          <list-item>
            <p>foreign body including use of colored contact lens</p>
          </list-item>
          <list-item>
            <p>Iron deposition: siderosis and hemosiderosis</p>
          </list-item>
          <list-item>
            <p>Melanocyte infiltration as in diffuse nevus or melanoma</p>
          </list-item>
          <list-item>
            <p>Local iris tumors</p>
          </list-item>
          <list-item>
            <p>Certain eyedrops such as prostaglandin analogs<xref ref-type="bibr" rid="article-140274.r18">[18]</xref><xref ref-type="bibr" rid="article-140274.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140274.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Heterochromia is an uncommon sign.&#x000a0;There is no widely reported prevalence.</p>
      </sec>
      <sec id="article-140274.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Human iris color exists in a continuum from light blue to dark brown. The most common description uses three shades, including blue, green-hazel, and brown. As discussed above, the most important determining factors for human iris color are the iris stromal texture and stromal melanocytes. The stromal melanocytes are derived from embryological neurocrest cells, which migrate through the uveal tract to the iris during fetal development. Subsequently, the iris stromal melanocytes are also under the trophic influence of the post-ganglionic cervical sympathetic pathway. Consequently, any unilateral lesion affecting the cervical sympathetic (Horner syndrome), either congenital or acquired within the first two years of life, will lead to heterochromia.<xref ref-type="bibr" rid="article-140274.r5">[5]</xref>&#x000a0;</p>
        <p>Very rarely, longstanding Horner syndrome may also result in heterochromia. Other diseases related to neurocrest cell development and migration may cause heterochromia, such as&#x000a0;Waardenburg syndrome&#x000a0;and Perry-Romberg syndrome.<xref ref-type="bibr" rid="article-140274.r8">[8]</xref><xref ref-type="bibr" rid="article-140274.r9">[9]</xref>&#x000a0;</p>
        <p>In addition to diseases primarily involving the iris melanocytes, any local eye or iris disease that causes a unilateral change in colors such as trauma with bleeding, melanoma and other tumors, and&#x000a0;Fuchs heterochromic iridocyclitis.<xref ref-type="bibr" rid="article-140274.r17">[17]</xref></p>
      </sec>
      <sec id="article-140274.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>History</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Onset: acute, subacute versus chronic - important in differentiating local eye disease vs. genetic causes. Progressive facial hemiatrophy is typical for Parry-Romberg syndrome.</p>
          </list-item>
          <list-item>
            <p>Any local eye symptoms such as pain, redness, and visual disturbances suggest local eye diseases.</p>
          </list-item>
          <list-item>
            <p>History of trauma.</p>
          </list-item>
          <list-item>
            <p>History of use of eye drops, especially used in one eye, causing discoloration of that eye such as latanoprost and other prostaglandin analog eyedrops.<xref ref-type="bibr" rid="article-140274.r18">[18]</xref></p>
          </list-item>
          <list-item>
            <p>Family history of neurofibromatosis type I</p>
          </list-item>
        </list>
        <p>
<bold>Physical</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Most important: Review old photos, especially childhood pictures. Look for the presence of heterochromia in the past and signs of Horner syndrome such as miosis and partial ptosis.</p>
          </list-item>
          <list-item>
            <p>Look for other signs of Horner syndrome - miosis and ptosis.</p>
          </list-item>
          <list-item>
            <p>Look for signs of specific syndromes such as cutaneous neurofibromata, facial hemiatrophy, facial port-wine stains, hearing loss, and broad facial features.</p>
          </list-item>
          <list-item>
            <p>Careful exam of the eye, especially the iris, anterior chamber, pupil size and responses, corneal conditions, and intraocular pressure measurement.<xref ref-type="bibr" rid="article-140274.r12">[12]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140274.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Eye examination by an ophthalmologist with a slit lamp examination. Clinical exam, especially to look for other signs of Horner syndrome.<xref ref-type="bibr" rid="article-140274.r16">[16]</xref></p>
        <p>Clinicians can use urinary&#x000a0;catecholamines, VMA, etc., for excessive sympathetic activities in children to rule out underlying neuroblastoma and other neurocrest derived tumors.</p>
        <p>CT chest and abdomen to causes of Horner syndrome or possible neuroblastoma or other tumors in&#x000a0;children and infants.<xref ref-type="bibr" rid="article-140274.r20">[20]</xref>&#x000a0;CT angiogram and CT skull base for hypoplasia of the internal carotid artery as proof of congenital Horner syndrome, or evidence of carotid dissection in chronic acquired Horner syndrome.</p>
        <p>Most of the time, with obviously isolated heterochromia and no other abnormal findings on physical exam, the diagnosis will be benign heterochromia. However, no further evaluation plus reassurance is adequate for the management of the patient.</p>
      </sec>
      <sec id="article-140274.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Heterochromia is a sign and not by itself a disease. There is no specific treatment of heterochromia by itself. Treatment is directed at the underlying cause, including underlying eye diseases. If the heterochromia is associated with other signs of Horner syndrome such as miosis and partial ptosis, the most common cause is congenital Horner syndrome which does not require any treatment. On the other hand, congenital or early childhood onset Horner syndrome may&#x000a0;result from an underlying tumor of the sympathetic chain, especially neuroblastoma which will need urgent workup, diagnosis, and treatment.<xref ref-type="bibr" rid="article-140274.r21">[21]</xref>&#x000a0;Heterochromia caused by an acquired Horner syndrome, especially in adults, signifies a chronic and longstanding illness. The underlying cause is very unlikely to be a malignancy.</p>
      </sec>
      <sec id="article-140274.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Heterochromia is a clinical sign. The differential diagnosis will include all the causes listed above. The most important differential diagnoses to consider are:</p>
        <list list-type="bullet">
          <list-item>
            <p>Benign isolated heterochromia</p>
          </list-item>
          <list-item>
            <p>Congenital Horner syndrome<xref ref-type="bibr" rid="article-140274.r16">[16]</xref></p>
          </list-item>
          <list-item>
            <p>Horner syndrome with onset before age of two</p>
          </list-item>
          <list-item>
            <p>Acquired longstanding Horner syndrome</p>
          </list-item>
          <list-item>
            <p>Heterochromia as part of other congenital syndromes</p>
          </list-item>
          <list-item>
            <p>Local iris and eye diseases including&#x000a0;Fuchs heterochromic iridocyclitis and melanoma<xref ref-type="bibr" rid="article-140274.r17">[17]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140274.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of heterochromia depends on the underlying cause. In infants and children, it is important to rule out underlying neoplasia of the sympathetic chain, especially neuroblastoma which carries a poor prognosis when diagnosed and treated late.<xref ref-type="bibr" rid="article-140274.r22">[22]</xref>&#x000a0;Fuchs heterochromic iridocyclitis may threaten vision due to complications of glaucoma. An iris melanoma may be malignant. The most common cause is benign heterochromia with no clinical significance. The other significant group of causes is congenital Horner syndrome which usually has a good prognosis.<xref ref-type="bibr" rid="article-140274.r16">[16]</xref></p>
      </sec>
      <sec id="article-140274.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Heterochromia is a clinical sign, and there is no health complication due to this sign per se.</p>
      </sec>
      <sec id="article-140274.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Ophthalmological consultation is indicated for most causes of local eye diseases causing heterochromia. Oncology consultation is often necessary with suspected underlying neuroblastoma in children.<xref ref-type="bibr" rid="article-140274.r23">[23]</xref></p>
      </sec>
      <sec id="article-140274.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>It&#x000a0;is most important to look at old pictures of the patient, especially childhood pictures. The presence of heterochromia since early childhood usually indicates benign heterochromia or congenital Horner syndrome.<xref ref-type="bibr" rid="article-140274.r16">[16]</xref>&#x000a0;No further workup is indicated, and the patient should be reassured.</p>
      </sec>
      <sec id="article-140274.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Heterochromia is a rare yet fascinating sign found in some patients, and it may cause unnecessary worries for the patients and families. These patients are usually first seen by their primary care doctors. Interprofessional care and communications between the primary care physician, ophthalmologist, and neurologist will&#x000a0;be most effective in determining the cause of the patient's heterochromia and appropriate management or reassurance.</p>
        <p>Making the final common diagnosis of benign heterochromia or congenital Horner syndrome by the healthcare team also helps the patient and family to understand the benign nature of the problem and reassurance about it being a non-inherited problem.</p>
      </sec>
      <sec id="article-140274.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140274&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140274">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/heterochromia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140274">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140274/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140274">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140274.s16">
        <fig id="article-140274.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Example of heterochromia. Created by wiki user Deanern1, used under Attribution-ShareAlike 3.0 Unported (CC BY-SA 3.0), https://creativecommons.org/licenses/by-sa/3.0/</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Kabir_Heterochromia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140274.s17">
        <title>References</title>
        <ref id="article-140274.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ur Rehman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Heterochromia.</article-title>
            <source>CMAJ</source>
            <year>2008</year>
            <month>Aug</month>
            <day>26</day>
            <volume>179</volume>
            <issue>5</issue>
            <fpage>447</fpage>
            <page-range>447-8</page-range>
            <pub-id pub-id-type="pmid">18725617</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prota</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Vincensi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Characterization of melanins in human irides and cultured uveal melanocytes from eyes of different colors.</article-title>
            <source>Exp Eye Res</source>
            <year>1998</year>
            <month>Sep</month>
            <volume>67</volume>
            <issue>3</issue>
            <fpage>293</fpage>
            <page-range>293-9</page-range>
            <pub-id pub-id-type="pmid">9778410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Imesch</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Wallow</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.</article-title>
            <source>Surv Ophthalmol</source>
            <year>1997</year>
            <month>Feb</month>
            <volume>41 Suppl 2</volume>
            <fpage>S117</fpage>
            <page-range>S117-23</page-range>
            <pub-id pub-id-type="pmid">9154287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tomar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dhiman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Artistic Iris: A Case of Congenital Sectoral Heterochromia Iridis.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2018</year>
            <season>Jul-Sep</season>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>359</fpage>
            <page-range>359-360</page-range>
            <pub-id pub-id-type="pmid">30090196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Renard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jeanjean</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Labauge</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Heterochromia Iridis in congenital Horner's syndrome.</article-title>
            <source>Eur Neurol</source>
            <year>2010</year>
            <volume>63</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <pub-id pub-id-type="pmid">20375515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diagne</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Sow</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ka</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Wane</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Ndoye Roth</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Ba</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>De Medeiros</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ndiaye</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Diallo</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Kane</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nguer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sy</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Ndiaye</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>[Rare causes of childhood leukocoria].</article-title>
            <source>J Fr Ophtalmol</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>8</issue>
            <fpage>676</fpage>
            <page-range>676-680</page-range>
            <pub-id pub-id-type="pmid">28893456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deprez</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Coulier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rommel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Boschi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Congenital horner syndrome with heterochromia iridis associated with ipsilateral internal carotid artery hypoplasia.</article-title>
            <source>J Clin Neurol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>192</fpage>
            <page-range>192-6</page-range>
            <pub-id pub-id-type="pmid">25749818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmological features and treatments in five cases of Waardenburg syndrome.</article-title>
            <source>Exp Ther Med</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>20</volume>
            <issue>4</issue>
            <fpage>3072</fpage>
            <page-range>3072-3077</page-range>
            <pub-id pub-id-type="pmid">32855674</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arif</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fatima</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sami</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Parry-Romberg syndrome: a mini review.</article-title>
            <source>Acta Dermatovenerol Alp Pannonica Adriat</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>193</fpage>
            <page-range>193-199</page-range>
            <pub-id pub-id-type="pmid">33348939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassanpour</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nourinia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gerami</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mahmoudi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Esfandiari</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Ocular Manifestations of the Sturge-Weber Syndrome.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2021</year>
            <season>Jul-Sep</season>
            <volume>16</volume>
            <issue>3</issue>
            <fpage>415</fpage>
            <page-range>415-431</page-range>
            <pub-id pub-id-type="pmid">34394871</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinti</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nemeth</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Staub</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lengyel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fekete</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Haltrich</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic difficulties and possibilities of NF1-like syndromes in childhood.</article-title>
            <source>BMC Pediatr</source>
            <year>2021</year>
            <month>Jul</month>
            <day>29</day>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>331</fpage>
            <pub-id pub-id-type="pmid">34325699</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarker</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Malek</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Abdullahi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iftekhar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sakeb</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mahatma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sarkar</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Ophthalmic associations of oculodermal melanocytosis in a tertiary eye hospital in South Asia.</article-title>
            <source>Ther Adv Ophthalmol</source>
            <year>2021</year>
            <season>Jan-Dec</season>
            <volume>13</volume>
            <fpage>2515841421993539</fpage>
            <pub-id pub-id-type="pmid">33644684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chaurasia</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Choudhari</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Clinical and Specular microscopy characteristics and corelation in Iridocorneal endothelial syndrome without corneal edema.</article-title>
            <source>Semin Ophthalmol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>03</day>
            <volume>36</volume>
            <issue>7</issue>
            <fpage>561</fpage>
            <page-range>561-568</page-range>
            <pub-id pub-id-type="pmid">33750265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cohen</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Incontinentia pigmenti.</article-title>
            <source>Neurol Clin</source>
            <year>1987</year>
            <month>Aug</month>
            <volume>5</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <page-range>361-77</page-range>
            <pub-id pub-id-type="pmid">3306331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wallis</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Granet</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>When the darker eye has the smaller pupil.</article-title>
            <source>J AAPOS</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>215</fpage>
            <page-range>215-6</page-range>
            <pub-id pub-id-type="pmid">12825064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Torres-Lobato</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>De Las Morenas-Iglesias</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Llemp&#x000e9;n-L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Mill&#x000e1;n-Ruiz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>M&#x000e1;rquez-Vega</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Espi&#x000f1;eira-Peri&#x000f1;&#x000e1;n</surname>
                <given-names>M&#x000c1;</given-names>
              </name>
              <name>
                <surname>Coronel-Rodr&#x000ed;guez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Franco-Ruedas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Balboa-Huguet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez-Vicente</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Paediatric Horner syndrome. A case series of 14 patients in a tertiary hospital.</article-title>
            <source>Arch Soc Esp Oftalmol (Engl Ed)</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>356</fpage>
            <page-range>356-365</page-range>
            <pub-id pub-id-type="pmid">34217473</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r17">
          <label>17</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Moshirfar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Villarreal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ronquillo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <chapter-title>Fuchs Uveitis Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>29</day>
            <pub-id pub-id-type="pmid">32644574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stjernschantz</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hu</surname>
                <given-names>DN</given-names>
              </name>
              <name>
                <surname>Drago</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wistrand</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Mechanism and clinical significance of prostaglandin-induced iris pigmentation.</article-title>
            <source>Surv Ophthalmol</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>47 Suppl 1</volume>
            <fpage>S162</fpage>
            <page-range>S162-75</page-range>
            <pub-id pub-id-type="pmid">12204714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doyle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>A case of acquired iris depigmentation as a possible complication of levobunolol eye drops.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1999</year>
            <month>Dec</month>
            <volume>83</volume>
            <issue>12</issue>
            <fpage>1405</fpage>
            <page-range>1405-6</page-range>
            <pub-id pub-id-type="pmid">10660314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Haller</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Legasto</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Imaging neuroblastoma in children.</article-title>
            <source>Crit Rev Comput Tomogr</source>
            <year>2003</year>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-61</page-range>
            <pub-id pub-id-type="pmid">12627783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abramson</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Berdon</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Ruzal-Shapiro</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Stolar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garvin</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cervical neuroblastoma in eleven infants--a tumor with favorable prognosis. Clinical and radiologic (US, CT, MRI) findings.</article-title>
            <source>Pediatr Radiol</source>
            <year>1993</year>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <page-range>253-7</page-range>
            <pub-id pub-id-type="pmid">8414748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Irwin</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Naranjo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>London</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Gastier-Foster</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ramirez</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Pfau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Reshmi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Nuchtern</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Asgharzadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shimada</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Maris</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Bagatell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Hogarty</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group.</article-title>
            <source>J Clin Oncol</source>
            <year>2021</year>
            <month>Oct</month>
            <day>10</day>
            <volume>39</volume>
            <issue>29</issue>
            <fpage>3229</fpage>
            <page-range>3229-3241</page-range>
            <pub-id pub-id-type="pmid">34319759</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140274.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Rhee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tracy</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Aldrink</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Baertschiger</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Lautz</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Glick</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Rodeberg</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Ehrlich</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Christison-Lagay</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee.</article-title>
            <source>J Pediatr Surg</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>57</volume>
            <issue>3</issue>
            <fpage>430</fpage>
            <page-range>430-442</page-range>
            <pub-id pub-id-type="pmid">34503817</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
